RaQualia Pharma Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-724.12	-357	-294	851	880	-527
Depreciation & Amortization	479.46	401	175	147	141	124
Loss (Gain) From Sale of Assets	-	-	-	-	-	1
Loss (Gain) From Sale of Investments	-	-3	-	35	-16	-1
Other Operating Activities	60.23	-100	-128	-203	-81	-85
Change in Accounts Receivable	-107.34	-85	-	603	-674	216
Change in Inventory	-9.77	3	-139	2	-4	-1
Change in Accounts Payable	4.44	-98	-134	111	136	-16
Change in Other Net Operating Assets	137.95	419	-198	-66	-16	-
Operating Cash Flow	-220.66	180	-718	1,480	366	-289
Operating Cash Flow Growth	-	-	-	304.37%	-	-
Capital Expenditures	-63.34	-96	-205	-31	-92	-149
Cash Acquisitions	-	-3,879	-	-	-	-
Sale (Purchase) of Intangibles	-2.94	-19	-17	-	-13	-6
Investment in Securities	400	158	90	-15	-174	380
Other Investing Activities	-5.17	171	-3	-1	-	-
Investing Cash Flow	328.55	-3,665	-135	-47	-279	225
Short-Term Debt Issued	-	400	-	-	10	-
Long-Term Debt Issued	-	3,357	50	13	-	-
Total Debt Issued	-	3,757	50	13	10	-
Short-Term Debt Repaid	-	-400	-	-	-10	-
Long-Term Debt Repaid	-	-387	-11	-2	-	-
Total Debt Repaid	-587.28	-787	-11	-2	-10	-
Net Debt Issued (Repaid)	-587.28	2,970	39	11	-	-
Issuance of Common Stock	1,099	80	805	4	1	-
Other Financing Activities	-52.2	-68	-51	-44	-17	-6
Financing Cash Flow	459.05	2,982	793	-29	-16	-6
Foreign Exchange Rate Adjustments	-24.02	-20	45	35	109	-68
Miscellaneous Cash Flow Adjustments	0	1	1	-1	-1	-
Net Cash Flow	542.92	-522	-14	1,438	179	-138
Free Cash Flow	-284	84	-923	1,449	274	-438
Free Cash Flow Growth	-	-	-	428.83%	-	-
Free Cash Flow Margin	-9.31%	2.70%	-48.55%	49.66%	9.87%	-39.57%
Free Cash Flow Per Share	-12.35	3.88	-42.72	69.06	13.06	-20.91
Cash Interest Paid	58.42	42	6	6	1	-
Cash Income Tax Paid	141.88	100	109	183	76	92
Levered Free Cash Flow	6.54	415.63	-694	1,172	64.88	-203.75
Unlevered Free Cash Flow	43.06	441.88	-689.63	1,176	65.5	-203.75
Change in Working Capital	-48.44	239	-471	650	-558	199

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.